SCOUT· 37%1h 42m·2026-07-28·BusinessEpisode 575: Dr. Jonathan Schoeff: Peptides and the Marketing Behind Modern Longevity - Part 2
Are you chasing longevity hacks while missing the habits that actually change your health? Everyone wants the shortcut. The GLP-1. The fasting protocol. The supplement. The perfect biomarker. The next thing that promises better energy, better body composition, and a longer life. But the real issue is that most people…
Scout bees are checking it out — divided opinions, the swarm hasn't committed.
- Platform
- 37%
- Community
- no read yet
- Value
- no read yet
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
What people are saying
“Soooo, I was all in and then the T bomb got dropped. All credibility is lost when TRT is admitted. Nevertheless, I appreciate the transparency.”
“So he's on test, now we know why. SMH”
“Yo this is fascinating. However, I do have questions that I’d love to ask in person. I will literally fly to you Mr. Schoeff.”
More from Habits and Hustle
See all episodes →
51%Episode 583: Dr. David Perlmutter: Brain Health Expert: The Daily Habits That Protect Your Brain as You Age
45%Episode 581: Dr. Joey Munoz: Nutrition Myths, Muscle Loss, and Sustainable Fat Loss
44%Episode 578: Attention, Comparison, and the Hidden Cost of Reality TV
Similar episodes from other shows
More like Habits and Hustle →
603. The TRUTH About GLPs and What You Can Do When They Disappear, How to Hack Muscle Growth and How to Really Anti-Age
65%Exercise Scientist: New Ozempic Data, Peptide Lies & The Dark Side of Steroids | Dr. Mike Israetel
Episode #158: Why Most People Are Ignoring the Game-Changing Potential of MOTS-C
#1 Monthly. Peptides, FDA Approval & Longevity Trends: Dr. Myles Spar Separates Science From Hype
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.